Correlation Between GeneReach Biotechnology and Chung Lien

Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Chung Lien at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Chung Lien into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneReach Biotechnology and Chung Lien Transportation, you can compare the effects of market volatilities on GeneReach Biotechnology and Chung Lien and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Chung Lien. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Chung Lien.

Diversification Opportunities for GeneReach Biotechnology and Chung Lien

0.73

Correlation Coefficient

GeneReach Biotechnology  Chung Lien

Poor diversification

The 3 months correlation between GeneReach and Chung is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Chung Lien Transportation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chung Lien Transportation and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Chung Lien. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chung Lien Transportation has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Chung Lien go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Chung Lien

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Chung Lien. In addition to that, GeneReach Biotechnology is 2.99 times more volatile than Chung Lien Transportation. It trades about -0.17 of its total potential returns per unit of risk. Chung Lien Transportation is currently generating about 0.02 per unit of volatility. If you would invest  4,190  in Chung Lien Transportation on September 22, 2024 and sell it today you would earn a total of  10.00  from holding Chung Lien Transportation or generate 0.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GeneReach Biotechnology  vs.  Chung Lien Transportation

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Chung Lien Transportation

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Chung Lien Transportation has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Chung Lien is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with GeneReach Biotechnology and Chung Lien

The main advantage of trading using opposite GeneReach Biotechnology and Chung Lien positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Chung Lien can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chung Lien will offset losses from the drop in Chung Lien's long position.

The idea behind GeneReach Biotechnology and Chung Lien Transportation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.